shanta dhar

[Nanoscale journal family @nanoscale_rsc]

How do you get to the mitochondria of a specific cancer cell type? A dual targeted nanoparticle offers such a navigation strategy.
@dharlab @SylvesterCancer @umiamimedicine

Read Nanoscale's inside front cover article by Shanta Dhar et al. here 👇:
https://t.co/82hViRRJ1K

[Sylvester Comprehensive Cancer Center @SylvesterCancer]

Five years after being awarded the prestigious National Cancer Institute (@theNCI) designation, we’ve earned it again. 🙌 As the only NCI-designated center in South Florida, we were recognized for our transformational new programs and initiatives, expanding our impact in our community since the first NCI designation. Our commitment to pursuing cancer cures continues: https://t.co/k3ozANDfh2. #OnlySylvester #WeAreNCIDesignated

[shanta dhar @DharShanta]

@michaelivanmd I can not wait to see all exciting outcomes from our collaborations. Thank you for being such an engaged collaborator and all the support

[shanta dhar @DharShanta]

@ashu83 @dharlab Thank you all your support

[shanta dhar @DharShanta]

Thank you @AcadofInventors for this honor, @SylvesterCancer and @DrSDNimer for promoting innovation, @universityofga where it began, @dharlab members for all amazing work, I am humbled to be part of this incredible class of fellows

[Sylvester Comprehensive Cancer Center @SylvesterCancer]

Join us in celebrating @DharShanta's induction into the National @AcadofInventors! This high professional distinction reflects her accomplishments in #technologies for mitochondrial #nanomedicine and her commitment to innovative #cancer therapies. ➡️ https://t.co/A6rYGY5ZeV

[National Academy of Inventors @AcadofInventors]

The National Academy of Inventors is proud to announce the Fellows Class of 2023!

The new class is comprised of 162 prolific academic innovators from over 115 research universities and research institutes worldwide.

View the Fellows Class of 2023: https://t.co/WUYyVBr3kD

[Monica Avila @monixavila]

Thank you for an amazing Inaugural Translational and Clinical Oncology Symposium! We look forward to next year’s event. #TCOSymposium @SylvesterCancer @JaimeMerchan10 @DrOlaLandgren @DrSDNimer

[ACS Central Science @ACSCentSci]

Repurposing Platinum(IV) Prodrugs to Modulate Mitochondrial Metabolism

NEW First Reactions by Raphaël Rodriguez & Emmanouil Zacharioudakis @institut_curie @EinsteinMed discussing work by @DharShanta & team https://t.co/LR8y0zmj6x
Read it here: https://t.co/jQZ7V0OarB

[ACS Central Science @ACSCentSci]

Our NEW issue is now live!
Read it here: https://t.co/KnUL3Q4Zfl

Front cover story by @DharShanta & team @SylvesterCancer 
https://t.co/7ZhogSUcPC

[Inside Precision Medicine @Inside_PM]

Scientists at @SylvesterCancer have developed a first-of-its-kind, orally administered drug that can disrupt #prostatecancer cell metabolism while simultaneously delivering the chemotherapy drug cisplatin directly. Learn more: https://t.co/q9HQtfne6b

[Sylvester Comprehensive Cancer Center @SylvesterCancer]

Researchers at Sylvester, led by Dr. Shanta Dhar, have developed an orally administered drug to disrupt #ProstateCancer cells’ metabolism and deliver a chemotherapy agent into treatment-resistant prostate cancer cells. Learn more about the discovery: https://t.co/SmAE0WI4xY

[nagesh kolishetti @polynag]

All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy | Bioconjugate Chemistry https://t.co/16Ty8YUAXC @dharlab @DharShanta

[DaltonTransactions @DaltonTrans]

👀Take a look at the recent work from @DharShanta, Bhabatosh Banik & co on the fabrication of nanoparticles containing Platin-C, as featured on one of the front covers of issue 12👇

https://t.co/l5sNPCwgbI

📍 @umiamimedicine, @universityofga, @univmiami, @CottonUniversi1

[Jash Datta, MD @DrJashDatta]

🚨Thrilled to announce that our grant was selected for funding by @DeptofDefense #DOD @CDMRP #IdeaDevelopmentAward mechanism! Excited to move forward nanoengineering concept to thwart pro-inflammatory signaling from neutrophilic MDSCs in #PancreaticCancer #pancsm w/ @DharShanta

[Sylvester’s Firefighter Cancer Initiative @fcifightscancer]

Heavy metals are naturally occurring elements that are toxic even with low-level exposure. These metals hide in burn sites and risk firefighters' health. Our study seeks to quantify the exposure. Contact us for opportunities to participate in our study: [email protected]

[Tina Papazotos @tinapapazotos]

#Perspective by @DharShanta, Tina Salguero and colleagues highlights barriers that #WomeninSTEM face in a post-pandemic world. A must-read for institutions looking for actionable ways to maintain #equity and support female scientists! @Scicommdylan

[Jill Biden Archived @FLOTUS46Archive]

Together, @theNCI and @SylvesterCancer are working to transform cancer care and save lives.

This research and dedication to patient care gives me hope that ending breast cancer as we know it is within our reach. #CancerMoonshot

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the 2022 #NobelPrize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.”

[Sylvester Comprehensive Cancer Center @SylvesterCancer]

We are proud to be among the best #cancer hospitals in the U.S. - and the only one in South Florida – recognized by @USNewsHealth in this year's #BestHospitals rankings!

[Bioconjugate Chem @BioconjChem]

Working with amphiphilic drugs? Hamdan et al @umiamimedicine address the solubility problems of hydrophobic antiviral drugs by formulating them into nanovesicles, enhancing the activity of the molecules in vitro and in mice.

https://t.co/ynwGm22oOL

@ACS_Omega